Treatment of recurrent hepatitis C after liver transplantation with IL-2r Ab

Transplantation Proceedings

Volumn 33, Issue 1-2, 2001, Pages 1087-1089

  Pinna, A D ^a   Ricordi, C ^b   Weppler, D ^a   Ruiz, P ^a   Tzakis, A G ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BILIRUBIN; INTERLEUKIN 2 RECEPTOR ANTIBODY; RIBAVIRIN; TACROLIMUS;

ADULT; CLINICAL ARTICLE; CONFERENCE PAPER; FEMALE; FOLLOW UP; HEPATITIS C; HUMAN; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL;

ANTIBODIES, MONOCLONAL; FEMALE; HEPATITIS C; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN-2; RECURRENCE;

EID: 0035077026     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(00)02428-3     Document Type: Conference Paper

References (2)

1. Asanza CG, Garcia-Monzon C, Clemente G, et al: Hepatology 26:755, 1997
2. Schirren CA, Jung MC, Worzfeld T, et al: Liver Transpl 6:222, 2000